BioSpace News Archive

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced the identification of antibody 23-H7, which preclinical data obtained to date indicates provides strong, protective anti-viral effects in SARS-CoV-2 (COVID-19) infected Syrian hamsters via an uncommon mechanism of action.

Ensemble Orthopedics, Inc. announced the first implantation of the FDA-cleared Ensemble CMC™, the first implant in a product line of minimally invasive joint replacements for the hand and wrist.

Immuneering Corporation today announced Carolina Garcia Rizo, Ph.D., MBA, has joined the company as chief business officer. Dr. Rizo brings to Immuneering extensive experience in the biotech and pharmaceutical industries, including senior-level leadership roles in global business development and strategy, machine learning (ML) based product development and commercial operations.

PORT-1 is the first asset from the Intensity platform of intratumoral amphiphilic formulations.

GoLiver Therapeutics, a start-up developing cell therapy products, has just received a one million euros grant from the French Government to support investment and to boost the competitiveness of French industry.

MobileODT, an Israeli Digital Health FemTech company that is producing the latest innovation in cervical cancer screening, is proud to announce that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the Dominican Republic.

Molecular Partners AG, a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced the nomination of Dominik Höchli, M.D., to the Company’s Board of Directors proposed for election at the 2021 Annual General Meeting on April 21, 2021.

Non-binding Heads of Terms for Co-development of MTX110; Unaudited Headline Results for the Year Ended 31 December 2020

Smith+Nephew, the global medical technology business, announces a marketing collaboration with Movendo Technology that will add personalised robotic patient rehabilitation capability to Smith+Nephew’s Real Intelligence enabling technology solutions, creating a fully digitised patient pathway from the pre-op stage to post-rehab phase.

Veeva Systems announced that TFS HealthScience will be the first CRO to have selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform.